170 related articles for article (PubMed ID: 7907810)
1. [Multiple drug resistance: a problem in cancer chemotherapy].
Lizano Soberón M; Barrera Rodríquez R
Rev Invest Clin; 1993; 45(5):481-92. PubMed ID: 7907810
[TBL] [Abstract][Full Text] [Related]
2. [Tumor resistance to multiple antineoplastic agents mediated by glycoprotein P: from the laboratory to the clinical field].
González-Manzano R
Med Clin (Barc); 1994 Apr; 102(13):506-15. PubMed ID: 7911549
[No Abstract] [Full Text] [Related]
3. [Multidrug resistance of neoplastic cells--facts and hypotheses].
Grzelakowska-Sztabert B
Postepy Biochem; 1989; 35(4):513-41. PubMed ID: 2577370
[No Abstract] [Full Text] [Related]
4. [Drug resistance genes].
Marie JP
Presse Med; 1992 Jun; 21(22):1033-7. PubMed ID: 1354869
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance due to P-glycoprotein.
Burt RK; Fojo AT; Thorgeirsson SS
Hosp Pract (Off Ed); 1990 Apr; 25(4):67-72, 74, 77. PubMed ID: 1969865
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance mediated by P-glycoprotein in haematological malignancies.
Pasman PC; Schouten HC
Neth J Med; 1993 Jun; 42(5-6):218-31. PubMed ID: 8104318
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in leukaemia.
Baines P; Cumber P; Padua RA
Baillieres Clin Haematol; 1992 Oct; 5(4):943-60. PubMed ID: 1364045
[TBL] [Abstract][Full Text] [Related]
8. Five putative drug resistance parameters (MDR1/P-glycoprotein, MDR-associated protein, glutathione-S-transferase, bcl-2 and topoisomerase IIalpha) in 57 newly diagnosed acute myeloid leukaemias. Swiss Group for Clinical Cancer Research (SAKK).
Lohri A; van Hille B; Bacchi M; Fopp M; Joncourt F; Reuter J; Cerny T; Fey MF; Herrmann R
Eur J Haematol; 1997 Oct; 59(4):206-15. PubMed ID: 9338618
[TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein-mediated multidrug resistance and cytotoxic effector cells.
Savas B; Cole SP; Akoglu TF; Pross HF
Nat Immun; 1992; 11(4):177-92. PubMed ID: 1358293
[TBL] [Abstract][Full Text] [Related]
10. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
11. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance and cancer.
Morrow CS; Cowan K
Adv Exp Med Biol; 1993; 330():287-305. PubMed ID: 8103619
[No Abstract] [Full Text] [Related]
13. Molecular targets in oncology: implications of the multidrug resistance gene.
Lum BL; Gosland MP; Kaubisch S; Sikic BI
Pharmacotherapy; 1993; 13(2):88-109. PubMed ID: 8097038
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance: P-glycoprotein and its allies--the elusive foes.
Chabner BA; Fojo A
J Natl Cancer Inst; 1989 Jun; 81(12):910-3. PubMed ID: 2567356
[No Abstract] [Full Text] [Related]
15. Mechanisms of multidrug resistance in cancer treatment.
Harris AL; Hochhauser D
Acta Oncol; 1992; 31(2):205-13. PubMed ID: 1352455
[TBL] [Abstract][Full Text] [Related]
16. [Atypical MDR].
Yokomizo A; Taniguchi K; Hasegawa S; Abe T; Kubo T; Makino Y; Wada M; Kohno K; Kuwano M
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1123-9. PubMed ID: 7913311
[TBL] [Abstract][Full Text] [Related]
17. [Expression of P-glycoprotein 170 (GP 170) and drug resistance in human cancers].
Bourhis J; Riou G; Bénard J
Bull Cancer; 1990; 77(10):957-65. PubMed ID: 1979014
[TBL] [Abstract][Full Text] [Related]
18. Glutathione S-transferase in chemotherapy resistance and in carcinogenesis.
Schecter RL; Alaoui-Jamali MA; Batist G
Biochem Cell Biol; 1992 May; 70(5):349-53. PubMed ID: 1353967
[TBL] [Abstract][Full Text] [Related]
19. Keynote address: multidrug resistance: a pleiotropic response to cytotoxic drugs.
Fairchild CR; Cowan KH
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):361-7. PubMed ID: 1671383
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.
Jain N; Lam YM; Pym J; Campling BG
Cancer; 1996 May; 77(9):1797-808. PubMed ID: 8646677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
